Home › Funds › KORNITZER CAPITAL MANAGEMENT INC /KS › GILD

KORNITZER CAPITAL MANAGEMENT INC /KS position in GILD

GILEAD SCIENCES INC · Health Care

KORNITZER CAPITAL MANAGEMENT INC /KS reported holding 318,355 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$47.5M, representing 0.99% of its reported portfolio and ranking #29 among its reported holdings. KORNITZER CAPITAL MANAGEMENT INC /KS has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)318.36K sh
Reported value held$47.45M
Portfolio Weight0.99%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How KORNITZER CAPITAL MANAGEMENT INC /KS's GILD position evolved

KORNITZER CAPITAL MANAGEMENT INC /KS first disclosed a stake in GILD in Q3 2023 at 376,495 shares (US$28.2M). The position peaked in Q3 2026 at 318,355 shares, worth US$47.5M. Across 13 filings, KORNITZER CAPITAL MANAGEMENT INC /KS increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 318,355 shares valued at US$47.5M — a reduction of -2,145 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 376.50K $28.21M New
Q4 2023 375.32K $30.41M Hold
Q1 2024 374.88K $27.46M Hold
Q2 2024 370.88K $25.45M Reduce
Q3 2024 370.85K $31.09M Hold
Q4 2024 359.70K $33.23M Reduce
Q1 2025 354.51K $39.72M Reduce
Q2 2025 349.49K $38.75M Reduce
Q3 2025 334.48K $37.13M Reduce
Q4 2025 328.85K $40.36M Reduce
Q1 2026 331.80K $46.24M Add
Q2 2026 320.50K $40.49M Reduce
Q3 2026 318.36K $47.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has KORNITZER CAPITAL MANAGEMENT INC /KS held GILD?

KORNITZER CAPITAL MANAGEMENT INC /KS has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KORNITZER CAPITAL MANAGEMENT INC /KS's current position in GILD?

As of Q3 2026, KORNITZER CAPITAL MANAGEMENT INC /KS holds 318.36K shares of GILD (GILEAD SCIENCES INC), valued at $47.45M, representing 0.99% of its reported portfolio and ranking #29.

Has KORNITZER CAPITAL MANAGEMENT INC /KS been buying or selling GILD?

In the latest 13F filing (Q3 2026), KORNITZER CAPITAL MANAGEMENT INC /KS reduced its position in GILD. The position peaked in Q3 2026 at 318.36K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.